The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes

详细信息	查看全文 | 推荐本文 |

• 作者：Cristiano Fava^a ; ^b ; ^{cristiano.fava@med.lu.se} ; ^{cristiano.fava@univr.it} ; Martina Montagnana^a ; ^c ; ¹ ; Elisa Danese^a ; ^b ; ^c ; ¹ ; Marketa Sj&ouml ; gren^a ; Peter Almgren^a ; Gian Cesare Guidi^c ; Bo Hedblad^a ; Gunnar Engstr&ouml ; m^a ; Pietro Minuz^b ; Olle Melander^a
• 关键词：Cytochrome P450 ; 20-HETE ; Genetics ; Metabolic syndrome ; CYP4F2 ; Triglycerides
• 刊名：Prostaglandins and Other Lipid Mediators
• 出版年：2012
• 期刊代码：31_10988823
• 类别：bio
• 出版时间：May, 2012
• 卷：98
• 期：1-2
• 页码：31-36
• 文件大小：227 K

摘要

Background and aim

The genetic basis of Metabolic syndrome (MetS) is largely unknown but a link with salt sensitivity is recognized. The cytochrome P450 isoform 4F2 (CYP4F2) is involved in renal production of 20-hydroxyeicosatethraenoic acid (20-HETE), a natriuretic substance associated with salt sensitivity. The same enzyme is implicated in 蠅-hydroxylation of very long and medium chain fatty acids in the liver suggesting its possible influence on gluco-metabolic components of MetS. The aim of the present study was to evaluate the effect of CYP4F2 V433M, a functional polymorphism previously associated with hypertension via renal salt reabsorption, on the individual components of MetS and MetS itself.

Methods

The polymorphism was genotyped in the cardiovascular cohort of the Malm枚 Diet and Cancer (MDC-CVA) study and successively in the Malm枚 Preventive Project (MPP) cohort. Different definitions of the MetS were applied.

Results

In the MDC-CVA, male, but not female, CYP4F2 M433 carriers had significantly higher levels of waist, triglycerides, BP and a composite sum of MetS phenotypes (MetS score) beside lower HDL-cholesterol respect to V-homozygotes. MetS, as defined in the ATPIII and the AHA/NHLBI definitions, was more prevalent in M-carriers with respect to V-homozygotes. In the MPP cohort, significant association was detectable only for triglycerides at baseline and for Diastolic BP at reinvestigation in male M-carriers.

Conclusion

The initial positive association of the CYP4F2 V433M polymorphism with components of MetS and MetS itself, found in MDC-CVA, was partially denied in another large cohort. The first association either could be due to a false positive result or alternatively, different genetic background or population stratification could have hidden the effect of the polymorphism in the replication cohort.